FDA unveils plans to boost innovation of medical devices

The US Food and Drug Administration (FDA) has announced a new programme to boost the innovation of safer medical devices and breakthrough technologies.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Biotechnology

FDA releases plan to boost biosimilars development

13 December 2018 The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.

Americas

FDA approved record number of novel devices in 2018

31 January 2019 A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.

More on this story

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA approved record number of novel devices in 2018

31 January 2019 A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.

Biotechnology

FDA releases plan to boost biosimilars development

13 December 2018 The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.

More on this story

Americas

FDA issues guidance on generic versions of complex drugs

11 October 2018 The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs.

Americas

FDA approved record number of novel devices in 2018

31 January 2019 A record number of novel devices were approved by the US Food and Drug Administration in 2018, the federal agency has said.

Biotechnology

FDA releases plan to boost biosimilars development

13 December 2018 The US Food and Drug Administration has announced new measures to advance the development of biosimilar medicines.